Summary:
An 8 week, randomized, double-blind, placebo and active-controlled, asthma study to evaluate the safety and efficacy of 3 doses of an active medication in asthmatic subjects
Qualified Participants Must:
• Male or female age 18-75
•
Already diagnosed with asthma by a doctor
• Poorly controlled asthma
•
COPD not allowed
•
No history of alcohol or drug abuse
Qualified Participants May Receive:
$50.00/visit: study drug: